Mouse Anti-HPV16 E7 Recombinant Antibody (clone 79A11) (CAT#: FAMAB-0192WJ)

The HPV16 E7 antibody 79A11 targets three exposed peptides of the HPV16 E7(49-66), HPV16 E7(73-85), and HPV16 E7(91-97). This antibody can be used in applications, such as ICC, IF, IHC, ELISA, WB, Neutralization.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Indirect ELISA assay for the purified mAb titer.

Figure 1 Indirect ELISA assay for the purified mAb titer.

The red dotted line presents S/N ratio = 2.1.

Hu, R., Dong, Z., Zhang, K., Pan, G., Li, C., & Cui, H. (2020). Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies. Viruses, 12(3), 333.

ICC

Figure 2 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunocytochemistry.

Figure 2 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunocytochemistry.

The 79A11 and 69E2 antibodies at the three dosages of 1.95, 6.25, and 50 µg/mL, respectively, were used to react with the HPV16-type cervical cancer cell line CaSki and the HPV18-type cervical cancer cell line HeLa in immunocytochemical reactions.

Hu, R., Dong, Z., Zhang, K., Pan, G., Li, C., & Cui, H. (2020). Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies. Viruses, 12(3), 333.

IF

Figure 3 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunofluorescence.

Figure 3 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunofluorescence.

The 79A11 and 69E2 mAbs, respectively, reacted with the CaSki and HeLa cervical cancer cell lines at a dose of 10 µg/mL in IF experiments.

Hu, R., Dong, Z., Zhang, K., Pan, G., Li, C., & Cui, H. (2020). Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies. Viruses, 12(3), 333.

IHC

Figure 4 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunohistochemistry.

Figure 4 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using immunohistochemistry.

The 79A11 and 69E2 mAbs reacted with the paraffin sections of HPV16 cervical squamous cell carcinoma and HPV18 cervical adenocarcinoma tissues at 8.95 and 50 µg/mL, respectively, in IHC assays.

Hu, R., Dong, Z., Zhang, K., Pan, G., Li, C., & Cui, H. (2020). Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies. Viruses, 12(3), 333.

WB

Figure 5 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using Western Blot.

Figure 5 Effectiveness and specificity of the anti-HPV16 E7 protein mAbs identified by using Western Blot.

The 79A11 and 69E2 mAbs reacted with CaSki cell protein extract at 10 µg/mL, respectively, in Western Blot experiments.

Hu, R., Dong, Z., Zhang, K., Pan, G., Li, C., & Cui, H. (2020). Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies. Viruses, 12(3), 333.


Specifications

  • Immunogen
  • HPV16 E7-HIS fusion oncoprotein
  • Host Species
  • Mouse
  • Derivation
  • Hybridoma
  • Type
  • Mouse IgM
  • Specificity
  • HPV16 E7
  • Species Reactivity
  • HPV16
  • Clone
  • 79A11
  • Applications
  • ICC, IF, IHC, ELISA, WB, Neut
  • Related Disease
  • HPV16 infection

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Human papillomavirus type 16; HPV16

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 79A11"

See other products for "HPV16 E7"

Intrabody

CAT Product Name Application Type
IAB-B047(A) Recombinant Anti-HPV16 E7 Intrabody [(D-Arg)9] ICC, Neut, FuncS scFv-(D-Arg)9
IAB-B047(G) Recombinant Anti-HPV16 E7 Intrabody [+36 GFP] ELISA, WB, ICC, FuncS scFv-(+36GFP)
IAB-B047(T) Recombinant Anti-HPV16 E7 Intrabody [Tat] IF, FC, WB, FuncS scFv-Tat

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for FAMAB-0192WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare